Short-TermMedium-TermLong-TermSignals

Prime Medicine Inc [PRME]

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Last Updated 23 Jun 2026 @ 13:33 (Exchange is open)
Last: $3.38 0.15%
-1.22 (↓)
GaG Algo Score™
v1.0
Short
-1.22 (↓)
Medium
-2.21 (↓)
Long
-2.64 (↓)

Stats

Today's Volume 1.48M
Average Volume 2.46M
Market Cap 608.68M
EPS $-0.280 (Q1 | 2026-05-07)
Next earnings date ($-0.240) 2026-08-06
Last Dividend $0.800 (2019-09-10)
P/E -2.74 (Sector) 26.21 (Industry) 17.28
ATR14 $0.270 (8.36%)
Possible DaySwing $3.10 - $3.37 (8.72%)

Support and Resistance Levels

Line

Pivot Data

Pivot Statistics
Metric Average Median Std Dev
Gain % 25.33% 25.33% 8.69%
Loss % -27.74% -27.74% 5.77%
Duration 14.3d 11d 8.7d
Total Pivots Found 5
Gain/Loss Legs 4 (2 Gain / 2 Loss)
Last Pivot Top @ $3.23 on 2026-06-18
Change since Last Pivot $0.00 (0.00%)
Next Pivot Prediction Last: $3.38
Predicted Next Type Bottom
Predicted Price (Avg) $2.33
Predicted Price (Median) $2.33
Predicted Price Range (~68%) $2.15 - $2.52
Change to Avg Target $-1.04 (-30.84%)
Predicted Date (Avg) 2026-07-02
Predicted Date Range (~68%) 2026-06-23 - 2026-07-10
Basis Based on 2 historical losses (Avg: -27.74%, Median: -27.74%, StdDev of Abs: 5.77%) and duration (Avg: 14.2 days, StdDev: 8.7 days)
Note Ranges assume ~normal distribution & historical patterns repeat. Use with caution.

Prime Medicine Inc rose moderately, up 2.22% on Thursday.

Prime Medicine Inc (PRME) stock price rose steadily on Thursday after the stock rose $0.0700 (2.22%) from the previous session on normal volume. The stock slightly outperformed the market today, moving slightly ahead of the NASDAQ's 1.91% rise. A total of 3.50M stocks were traded yesterday, valued at $11.31M, 709 702 shares less than the previous day (4 211 334 shares traded). This is near the average volume for the stock at 2.92M shares traded per day.

Prime Medicine Inc signals

There is no conclusive signals given from RSI. The price is below both moving averages, and the short-term average is below the long-term average, confirming a sustained down-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (-16.7%), medium- (-16.7%), and long-term (-16.7%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

Prime Medicine Inc Support & Resistance Levels

The stock is approaching the closest resistance level at $3.24. approximately $0.0100 (0.31%) away. Pushing up towards resistance. Breaking above this level could signal further upside where next resistance level will be found at $3.64. On a fall back there will be support at $3.12 The dis das resistance s13.12 -

Prime Medicine Inc Evaluation

  • Short score: -1.22
  • Medium score: -2.21
  • Long score: -2.64